Results 91 to 100 of about 15,796 (188)

The cardiorenal problem

open access: yesSwiss Medical Weekly, 2014
Cardiorenal syndrome (CRS) describes the reciprocally detrimental interaction between both acute and chronic cardiac and renal dysfunction. The syndrome is prevalent and carries a high mortality.
Emiliy Pollock, Albina Nowak
doaj   +1 more source

Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study [PDF]

open access: yes, 2012
Introduction: Fluid overload is a clinical problem frequently related to cardiac and renal dysfunction. the aim of this study was to evaluate fluid overload and changes in serum creatinine as predictors of cardiovascular mortality and morbidity after ...
Araujo, Lilian   +9 more
core   +2 more sources

Inhaled Halogen‐Induced Oxidative Renal Damage and Dysfunction: A Lung Heart Kidney Axis

open access: yesComprehensive Physiology, Volume 16, Issue 1, February 2026.
Mechanisms of lung‐heart‐kidney interaction in inducing organ injury after chemical inhalation. Acute exposure to halogen gases causes extensive lung injury and acute cardiac damage leading to fatalities. Formation of highly reactive halogenated molecules in the pulmonary bed and their circulation resulting in oxidative stress and inflammation was ...
Juan Xavier Masjoan Juncos   +9 more
wiley   +1 more source

Data on the stem cells paracrine effects on apoptosis and cytokine milieu in an experimental model of cardiorenal syndrome type II

open access: yesData in Brief, 2018
The data reported in this article are related to the paper entitle “Stem cells transplantation positively modulates the heart-kidney cross talk in Cardiorenal Syndrome Type II” (Vescovo et al., 2019), which analyzed the impact of stem cells injection in ...
Giorgio Vescovo   +7 more
doaj   +1 more source

Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. [PDF]

open access: yes, 2011
Little is known about the effect of anemia correction with erythropoietin (EPO) on B-type natriuretic peptide (BNP) levels, NYHA class, and hospitalization rate.
Antonelli, G   +7 more
core   +1 more source

Thyroid hormone and heart failure: from myocardialprotection to systemic regulation [PDF]

open access: yes, 2014
Heart failure (HF) is an intriguing model of chronic disease. It starts as an organ disorder developing, in its progression, into a systemic disease in which the dysfunction of other organs plays a relevant clinical and prognostic impact.
Iervasi, Giorgio   +2 more
core   +1 more source

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. [PDF]

open access: yes, 2019
Background We tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident atrial fibrillation (AF) in a prospective study of chronic kidney disease patients.
Anderson, Amanda H   +22 more
core  

Cardiorenal and hepatorenal syndrome

open access: yesJournal of Pediatric Critical Care, 2018
Cardiorenal syndrome(CRS) is an interdependent involvement of the heart and the kidney that leads to high morbidity, recurrent readmissions and grave prognosis.
Anand Bhutada   +3 more
doaj   +1 more source

Renal replacement therapy in acute kidney injury: controversy and consensus [PDF]

open access: yes, 2015
Renal replacement therapies (RRTs) represent a cornerstone in the management of severe acute kidney injury. This area of intensive care and nephrology has undergone significant improvement and evolution in recent years.
A Davenport   +134 more
core   +5 more sources

Successful Percutaneous Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in a High-risk Patient with Cardiorenal Syndrome

open access: yesUS Cardiology Review
The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe the successful treatment of an 84-year-old
Deniz Mutlu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy